Heptares Therapeutics

  • Founded in 2007
  • Employees: 50

Description :

Heptares discovers and develops new medicines targeting GPCRs (G protein-coupled receptors), a super-family of drug targets linked to a wide range of human diseases. Heptares has been aquired by Sosei, Japan. Their partnerships include Teva (Israel) Takeda (Japan / Cambridge UK), AstraZeneca, Cubist Pharma (MA, US), MorphoSys and MedImmune.

Headquarters :

Broadwater Road Welwyn Garden City, Hertfordshire United Kingdom

Related Posts

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and it's freely accessible content.